Enhanced resistance to acute infection with Trypanosoma cruzi in mice treated with an interferon inducer.
For an exploration of the effects of interferon-inducible resistance mechanisms in acute American trypanosomiasis, the synthetic interferon inducer tilerone hydrochloride was administered to mice of the C57BL/6J strain, which is highly resistant to Trypanosoma cruzi, 18 to 24 h before infection with a potentially lethal dose of bloodstream trypomastigotes. Although all of the control mice died within 30 days of the acute infection, approximately 50% of the tilerone-treated animals were able to survive indefinitely (P less than 0.05). The tilerone-treated mice demonstrated significant levels of serum interferon and splenic natural killer cells at the time of infection. Macrophages isolated from the peritoneal cavities of tilerone-treated C57BL/6J mice appeared to kill significant numbers of trypanosomes during 2 to 3 days of in vitro culture, indicating that activated macrophages may contribute to the enhanced resistance to T. cruzi infection in these mice. Beige mice treated with tilerone did not survive T. cruzi infection as well as tilerone-treated heterozygotes did, suggesting a role for natural killer cells in interferon-induced resistance. These results suggest that interferon or effector mechanisms enhanced by interferon induction can play a significant role in influencing resistance to T. cruzi infection.
D000818:Animals; D014355:Chagas Disease / Q000276:immunology*; D005260:Female; D005449:Fluorenes / Q000494:pharmacology*; D007109:Immunity; D007372:Interferons / Q000097:blood; D007694:Killer Cells, Natural / Q000502:physiology*; D008264:Macrophages / Q000502:physiology*; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D009154:Mutation; D013994:Tilorone / Q000494:pharmacology*
D005449:Fluorenes; D007372:Interferons; D013994:Tilorone